Clinical Trial

Food Typologies and Multidimensional Phenotyping of Elderly in Auvergne-Rhône-Alpes (Part'AGE)

Study acronym: Part'AGE
Recruiting
View on ClinicalTrials.gov →
Summary
To better understand how diet influences health during aging, the French National Research Institute for Agriculture, Food and the Environment (INRAE) is working with the Gérontopôle Auvergne-Rhône-Alpes on a project called Part'AGE. Part'AGE is a participatory research project where researchers want to recruit 1,000 people aged between 55 and 75 years, men and women, living in Auvergne-Rhône-Alpes in urban or rural areas. The goal is to study eating habits and state of health. To do this, researchers will examine many factors that can influence them, such as physical activity, overall health, consumption patterns or territories. Researchers will collect detailed information to classify participants into different groups (food typologies) based on their eating habits and state of health. With this distribution, the goal is to be able to give each group personalized nutritional advice to age in better health. To participate in the study, the participants will need to collect a few drops of blood from the end of the finger, a urine sample, and do some tests (mobility, oral health). It will also be necessary to fill out questionnaires on eating habits, physical activity, and other aspects that may influence health. The benefices for to participants will be to contribute to nutrition research and to receive personalized feedback and advices on eating habits.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-11-18; most recent amendment 2026-03-24.
Status change: Not Yet Recruiting → Recruiting 2025-02-12
Trial Details
NCT Number NCT06695780
Lead Sponsor Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement
Collaborators: Icadom, Centre de Recherche en Nutrition Humaine Rhone-Alpe
Conditions Nutritional Assessment, Physical Activity, Health, Oral Health
Enrollment 1,000 participants
Start Date 2025-02-03
Primary Completion 2027-02 (estimated)
Study Completion 2028-02 (estimated)
Updated on ClinicalTrials.gov 2026-03-27